AIC gets approval to market implants in Europe.
Active's implants react to the body's movements in a way which enables them to mimic the flexibility of the original cartilage.
The company's products are polymer implants intended for orthopedic use as substitutes for bone and cartilage. Active's implants react to the bodies movements in a way which enables them to mimic the flexibility of the original cartilage. The product which was approved is an implant intended for the hip-joints.
A number of months ago, AIC reported the completion of its first financing round, in which it raised $10 million, mostly from private strategic investors from Tennessee.
Published by Globes [online], Israel business news - www.globes.co.il - on September 19, 2006
© Copyright of Globes Publisher Itonut (1983) Ltd. 2006
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options